Harbor Investment Advisory LLC Has $659,000 Holdings in Zoetis Inc. (NYSE:ZTS)

Harbor Investment Advisory LLC lowered its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 38.9% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,003 shares of the company's stock after selling 2,544 shares during the quarter. Harbor Investment Advisory LLC's holdings in Zoetis were worth $659,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its position in shares of Zoetis by 10.6% in the third quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company's stock valued at $569,834,000 after buying an additional 279,092 shares during the last quarter. Brighton Jones LLC grew its stake in Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock worth $754,000 after acquiring an additional 2,978 shares during the period. OLD National Bancorp IN raised its holdings in Zoetis by 31.3% in the 4th quarter. OLD National Bancorp IN now owns 1,552 shares of the company's stock valued at $253,000 after acquiring an additional 370 shares during the last quarter. Chicago Partners Investment Group LLC lifted its stake in shares of Zoetis by 4.6% during the 4th quarter. Chicago Partners Investment Group LLC now owns 2,633 shares of the company's stock worth $434,000 after purchasing an additional 115 shares during the period. Finally, Independence Bank of Kentucky boosted its holdings in shares of Zoetis by 65.6% during the fourth quarter. Independence Bank of Kentucky now owns 1,043 shares of the company's stock worth $170,000 after purchasing an additional 413 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Wall Street Zen upgraded Zoetis from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. UBS Group cut their price objective on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a report on Wednesday, May 7th. Morgan Stanley decreased their target price on shares of Zoetis from $243.00 to $238.00 and set an "overweight" rating on the stock in a research report on Friday, February 14th. Barclays upped their price target on shares of Zoetis from $242.00 to $244.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Finally, Stifel Nicolaus decreased their price target on shares of Zoetis from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Monday, April 14th. One analyst has rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average price target of $212.75.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 326 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $170.00, for a total value of $55,420.00. Following the completion of the sale, the executive vice president now owns 15,781 shares in the company, valued at $2,682,770. This represents a 2.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Willie M. Reed sold 1,210 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total transaction of $201,029.40. Following the sale, the director now owns 11,245 shares of the company's stock, valued at $1,868,244.30. The trade was a 9.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,188 shares of company stock valued at $367,289. Company insiders own 0.18% of the company's stock.

Zoetis Price Performance

ZTS remained flat at $168.59 on Thursday. The company had a trading volume of 2,773,860 shares, compared to its average volume of 2,539,221. Zoetis Inc. has a 1 year low of $139.70 and a 1 year high of $200.33. The firm has a 50-day moving average of $157.16 and a 200 day moving average of $164.46. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75. The firm has a market cap of $75.06 billion, a PE ratio of 30.82, a price-to-earnings-growth ratio of 2.78 and a beta of 0.94.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The business had revenue of $2.22 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period in the previous year, the business earned $1.38 EPS. The business's quarterly revenue was up 1.4% on a year-over-year basis. As a group, research analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.19%. Zoetis's dividend payout ratio is presently 35.91%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.